L. Kobak, O. Abrahamovych, U. Abrahamovych, V. Chemes
Danylo Halytsky Lviv National Medical University
Context. The prevalence and incidence of systemic lupus erythematosus (SLE) in the world is significant. In recent years, there has been a tendency of the SLE prevalence increase. despite the undoubted progress in understanding the etiology and pathogenesis of SLE, its diagnosis and treatment, the mortality of patients, including ones at young and working age, is higher than in the general population, and circulatory system lesions are ones of its main reasons in these cases.
Objective. To analyze the literature, dedicated to the modern view on the problem of systemic lupus erythematosus with and without comorbid lesions of the circulatory system, describe the clinical case.
Materials and methods. Content analysis, method of system and comparative analysis, bibliosemantic method of studying the current scientific investigations on modern principles of diagnosis and treatment of patients with SLE are used. A clinical case is described.
Results. The article presents modern ideas about the etiological factors and pathogenesis of the disease. The clinical manifestations of SLE are very diverse. The problem of comorbidity and syntropy of lesions is relevant. Lesions of the cardiovascular system in the case of SLE can manifest itself in the form of pericarditis, myocarditis, endocarditis, lesions of the heart valves, coronary arteries, aorta, conduction system, pulmonary hypertension occurrence. The basic principles of drug therapy are also briefly considered.
Conclusions. The results of the literature review indicate the importance of the problem of systemic lupus erythematosus, due to its widespread prevalence among the young and people of working age, lack of accurate knowledge about the etiology and pathogenesis of the disease, comorbid lesions of many organs and systems, including circulatory system, the development of severe and often life-threatening manifestations, the lack of clear recommendations that would predict the differentiated use of drugs taking into account comorbid syntropic lesions, which is also demonstrated in the described clinical case. Given this, systemic lupus erythematosus needs further in-depth study.
References
- Abrahamovych O, Abrahamovych U, Guta S, Farmaha M, Kobak L. Cytomegalovirus and Virus Epstein-Barr Infection in Patients With Systemic Lupus Erythematosus and Its Dependence on Gender and Age of Patients. World Sci. 2020;8(60):0-6 (Ukrainian) https://doi.org/10.31435/rsglobal_ws/31102020/7225
- Abrahamovych О, Abrahamovych U, Kushyna A, Guta S, Farmaha M. Dependence of heart rate іn terms of the daіly monіtorіng іndіcators on the actіvіty of pathologіcal process іn patіents wіth systemіc lupus erythematosus Georgіan Medіcal News. 2016;10(259):53-57 (Ukrainian)
- Abrahamovych О, Abrahamovych U, Kushyna A, Guta S, Synenkyi O. Dependence of Indicators of Daily Blood Pressure Monitoring on Activity of Pathological Process in Patients with Systemic Lupus Erythematosus. Lviv clinical bulletin. 2016;2(14)-3(15):14-22 (Ukrainian) https://doi.org/10.25040/lkv2016.023.014
- Abrahamovych O, Fayura O, Abrahamovych U. Comorbidity: a Modern View on the Problem; Classification (first notice). Lviv clinical bulletin. 2015;4(12):56-64 (Ukrainian) https://doi.org/10.25040/lkv2015.04.056
- Abrahamovych O, Fayura O, Abrahamovych U. Comorbidity: a Modern View on the Problem; Classification (second notice). Lviv clinical bulletin. 2016;1(13):31-39 (Ukrainian) https://doi.org/10.25040/lkv2016.01.031
- Abrahamovych U, Abrahamovych O, Nadashkevich O, Farmaha M, Kobak L. Pathogenetic Association of Digestive System Lesions with Systemic Lupus Erythematosus: Characteristics and Prevalence. Psychosom Med Gen Pract. 2020;5(1):e0501225 (Ukrainian) https://doi.org/10.26766/pmgp.v5i1.225
- Abrahamovych UO, Abrahamovych OO, Farmaha ML, Romaniuk OT, Kobak LO. Pаthogenetic association of vascular and cardiac lesions with systemic lupus erythematosus: charasteristics and prevalence. Art of Medicine. 2020;2(14):6-15 (Ukrainian) https://doi.org/10.21802/artm.2020.2.14.6.
- Ajeganova S, Gustafsson T, Jogestrand T. Bone mineral density and carotid atherosclerosis in systemic lupus erythematosus: a controlled cross-sectional study. Arthritis Res. Ther. 2015;17(1):84. https://doi.org/10.1186/s13075-015-0595-4
- Al Rayes H, Harvey PJ, Gladman DD, Su J, Sabapathy A, Urowitz MB, Touma Z. Prevalence and associated factors of resting electrocardiogram abnormalities among systemic lupus erythematosus patients without cardiovascular disease. Arthritis Research & Therapy. 2017;19:31. https://doi.org/10.1186/s13075-017-1240-1
- Amosova KM, Yaremenko OB, Matiyashchuk IG. Traditional and specific risk factors of atherosclerosis in patients with systemic lupus erythematosus. Ukrainian Journal of Rheumatology. 2012;1:5-11 (Ukrainian)
- An J, Minie M, Sasaki T. Antimalarial Drugs as Immune Modulators: New Mechanisms for Old Drugs. Annu Rev. Med. 2017;68:317-330. https://doi.org/10.1146/annurev-med-043015-123453
- Andreoli L, Bertsias GK, Agmon-Levin N. EULAR recommendations for women’s health and the management of family planning, assisted reproduction, pregnancy and menopause in patients with systemic lupus erythematosus and/or antiphospholipid syndrome. Ann. Rheum. Dis. 2016. https://doi.org/10.1136/annrheumdis-2016-209770
- Angel A, Justiz V, Amandeep G et al. Systemic Lupus Erythematosus (SLE). StatPearls Publishing, Treasure Island (FL), 2020 Jan.
- Apostolopoulos D, Kandane-Rathnayake R, Raghunath S. Independent association of glucocorticoids with damage accrual in SLE. Lupus Sci Med. 2016;3:e000157. https://doi.org/10.1136/lupus-2016-000157
- Aringer M, Costenbader K, Daikh D et al. European League Against Rheumatism/American College of Rheumatology classification criteria for systemic lupus erythematosus. Ann Rheum Dis. 2019;78(9):1151-1159.
- Aringer M, Dorner T, Leuchten N, Johnson SR. Toward new criteria for systemic lupus erythematosus – a standpoint. Lupus. 2016;25:805-811. https://doi.org/10.1177/0961203316644338
- Aringer M, Schneider M. Management of systemic lupus erythematosus. Internist (Berl). 2016;57(11):1052-1059. https://doi.org/10.1007/s00108-016-0135-6
- Artola RT, Mihos CG, Santana O. Effects of Statin Therapy in Patients with Systemic Lupus Erythematosus. South Med. J. 2016;109(11):705-711.
- Azrielant S, Tiosano S, Watad A. Correlation between systemic lupus erythematosus and malignancies: a cross-sectional population-based study. Immunol Res. 2017;1-6. https://doi.org/10.1007/s12026-016-8885-8
- Bani Hani A, Abu-Abeeleh M, Al Kharabsheh MM, Qabba’ah L. Libman-Sacks Endocarditis with Unusual Large Size Vegetation Involving the Mitral Valve. Heart Surg Forum. 2016;19(6):E294-E296. https://doi.org/10.1532/hsf.1612
- Belibou C, Ancuta C, Ancuta E, Filos C, Chirieac R. Carotid intima-media thickness and plaque as surrogate biomarkers of atherosclerosis amond consecutive women with systemic lupus erythematosus. Rom J Morphol Embryol. 2012;53(1):29-34.
- Beloglazov VA, Shaduro DV, Gordienko AI, Bakova AA. Imbalance of the humoral link of antiendotoxin immunity and its influence on systemic inflammation, endogenous intoxication in patients with systemic lupus erythematosus. Immunology and Allergy: Science and Practice. 2014;2:45-51 (Ukrainian)
- Beregniy V, Marushko T, Marushko I. Characteristic of cardiac lesion in patients with systemic lupus erythematosus. Modern Pediatrics. 2010;6(34):128-131 (Ukrainian)
- Binello N, Cancelli C, Passalacqua S et al. Use of Intravenous Immunoglobulin Therapy at Unconventional Doses in Refractory Fulminant Systemic Lupus Erythematosus. Eur J Case Rep Intern Med. 2018;5(9):000934. https://doi.org/10.12890/2018_000934
- Bogmat LF, Shevchenko NS, Matvienko EV. Use of SLICC/ACR damage index in adolescent with SLE. Ukrainian Journal of Rheumatology. 2015;2:42-45 (Ukrainian)
- Bourré-Tessier J, Urowitz MB, Clarke AE, Bernatsky S, Krantz MJ, Huynh T et al. Electrocardiographic findings in systemic lupus erythematosus: data from an international inception cohort. Arthritis Care Res (Hoboken). 2014;67(1):128-135. https://doi.org/10.1002/acr.22370
- Chakravarty EF. Incidence and Prevention of Herpes Zoster Reactivation in Patients with Autoimmune Diseases. Rheum Dis Clin North Am. 2017;43(1):111-121. https://doi.org/10.1016/j.rdc.2016.09.010
- Cheetham TC, Marcy SM, Tseng H, Sy LS, Liu IA, Bixler F et al. Risk of herpes zoster and disseminated varicella zoster in patients taking immunosuppressant drugs at the time of zoster vaccination. Mayo Clin Proc. 2015;90(7):865-873. https://doi.org/10.1016/j.mayocp.2015.04.021
- Chen HL, Shen L-J, Hsu P-N et al. Cumulative Burden of Glucocorticoid-related Adverse Events in Patients with Systemic Lupus Erythematosus: Findings from a 12-year Longitudinal Study. J Rheumatol. 2018;45(1):83-89. https://doi.org/10.3899/jrheum.160214
- Choi MY, Clarke AE, St Pierre Y, Hanly JG, Urowitz MB, Romero-Diaz J et al. Antinuclear Antibody-Negative Systemic Lupus Erythematosus in an International Inception Cohort. Arthritis Care Res (Hoboken). 2019;71(7):893-902. https://doi.org/10.1002/acr.23712
- Christou EAA, Banos A, Kosmara D et al. Sexual dimorphism in SLE: above and beyond sex hormones. Lupus. 2019;28(1):3-10. https://doi.org/10.1177/0961203318815768
- Dall’Ara F, Andreoli L, Piva N. Winter lupus flares are associated with low vitamin D levels in a retrospective longitudinal study of Italian adult patients. Clin Exp Rheumatol. 2015;33(2):153-158.
- Di Virgilio F, Giuliani AL. Purinergic signalling in autoimmunity: A role for the P2X7R in systemic lupus erythematosus? Biomed J. 2016;39(5):326-338. https://doi.org/10.1016/j.bj.2016.08.006
- Dolcino M, Puccetti A, Barbieri A, Bason C, Tinazzi E, Ottria A et al. Infections and autoimmunity: role of human cytomegalovirus in autoimmune endothelial cell damage. Lupus. 2015;24:419-432. https://doi.org/10.1177/0961203314558677
- Domingues V, Magder LS, Petri M. Assessment of the independent associations of IgG, IgM and IgA isotypes of anticardiolipin with thrombosis in SLE. Lupus Sci Med. 2016;3:126-131. https://doi.org/10.1136/lupus-2015-000107
- Eder L, Gladman DD, Ibañez D, Urowitz MB. The correlation between carotid artery atherosclerosis and clinical ischemic heart disease in lupus patients. Lupus. 2014;23(11):1142-1148.
https://doi.org/10.1177/0961203314537696 - Elnady BM, Abdelghafar AS, Khalik ES. The implication of tissue Doppler echocardiography and cardiopulmonary exercise in early detection of cardiac dysfunction in systemic lupus erythematosus patients. Eur J Rheumatol. 2016;3(3):109-117. https://doi.org/10.5152/eurjrheum.2016.16002
- Fanouriakis A, Kostopoulou M, Alunno A et al. 2019 update of the EULAR recommendations for the management of systemic lupus erythematosus. Ann Rheum Dis. 2019;78:36-745. https://doi.org/10.1136/annrheumdis-2019-215089
- Fanouriakis A, Kostopoulou M, Cheema K et al. 2019 Update of the Joint European League Against Rheumatism and European Renal Association-European Dialysis and Transplant Association (EULAR/ERA-EDTA) recommendations for the management of lupus nephritis. Ann Rheum Dis. 2020;79(6):713-723. https://doi.org/10.1136/rmdopen-2020-001263
- Finzel S, Schaffer S, Rizzi M et al. Pathogenese des systemischen Lupus erythematodes [Pathogenesis of systemic lupus erythematosus]. Z Rheumatol. 2018;77(9):789-798. https://doi.org/10.1007/s00393-018-0541-3
- Frieri M, Stampfl H. Systemic lupus erythematosus and atherosclerosis: Review of the literature. Autoimmun Rev. 2016;15(1):16-21. https://doi.org/10.1016/j.autrev.2015.08.007
- Fujiwara S, Takei M. Epstein-Barr virus and autoimmune diseases. Clin Exp Neuroimmunol. 2015;6(1):38-48. https://doi.org/10.1111/cen3.12263
- Garcia-Carrasco M, Romero-Galvez JL. Vitamin D and cardiovascular disease in patients with systemic lupus erythematosus. Reumatol Clin. 2016;12:241-243. https://doi.org/10.1016/j.reumae.2016.07.003
- García-Villegas EA, Márquez-González H, Flores-Suárez LF, Villa-Romero AR. The pulse-mass index as a predictor of cardiovascular events in women with systemic lupus erythematosus. Med Clin (Barc). 2017;148(2):57-62. https://doi.org/10.1016/j.medcli.2016.09.017
- Gergianaki I, Bertsias G. Systemic Lupus Erythematosus in Primary Care: An Update and Practical Messages for the General Practitioner. Front Med (Lausanne). 2018;5:161. https://doi.org/10.3389/fmed.2018.00161
- Gomez Mendez LM, Cascino MD, Garg J et al. Peripheral Blood B Cell Depletion after Rituximab and Complete Response in Lupus Nephritis. Clin J Am Soc Nephrol. 2018;13(10):1502-1509. https://doi.org/10.2215/CJN.01070118
- Gustafsson J. Studies on cardiovascular risk factors in Systemic Lupus Erythematosus. Stockholm: Karolinska Institutet; 2012. 71 p.
- Guy A, Tiosano S, Comaneshter D. Aortic aneurysm association with SLE – a case-control study. Lupus. 2016;25(9):959-963. https://doi.org/10.1177/0961203316628999
- Haładyj E, Paradowska-Gorycka A, Felis-Giemza A, Olesińska M. Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome. Reumatologia. 2016;54(4):187-195. https://doi.org/10.5114/reum.2016.62473
- Han GM, Han XF. Comorbid Conditions are Associated With Emergency Department Visits, Hospitalizations, and Medical Charges of Patients With Systemic Lupus Erythematosus. J Clin Rheumatol. 2017;23(1):19-25. https://doi.org/10.1097/RHU.0000000000000437
- Hatef-Fard MR, Khodabandeh M, Sahebari M. Metabolic syndrome in lupus patients in northeast of Iran, and their lifestyle habits. Caspian J Intern Med. 2016;7(3):195-200.
- He Y, Huang Y, Tu L. Decreased Gαq expression in T cells correlates with enhanced cytokine production and disease activity in systemic lupus erythematosus. Oncotarget. 2016;7(52):85741-85749. https://doi.org/10.18632/oncotarget.13903
- He Y, Sawalha AH. Drug-induced lupus erythematosus: an update on drugs and mechanisms. Curr Opin Rheumatol. 2018;30(5):490-497. https://doi.org/10.1097/BOR.0000000000000522
- Hermansen ML, Lindhardsen J, Torp-Pedersen C. The risk of cardiovascular morbidity and cardiovascular mortality in systemic lupus erythematosus and lupus nephritis: a Danish nationwide population-based cohort study. Rheumatology (Oxford). 2017;56(5):709-715. https://doi.org/10.1093/rheumatology/kew475
- Herrinton LJ, Liu L, Goldfien R, Michaels MA, Tran TN. Risk of serious infection for patients with systemic lupus erythematosus starting glucocоrticoids with or without antimalarials. J Rheumatol. 2016;43:1503-1509. https://doi.org/10.3899/jrheum.150671
- Heshmat TS, Khalil NM, Elhamid HA, Labib S, Mahfouz M. Assessment of premature coronary atherosclerosis in patients with systemic lupus erythematosus disease. Egyptian Rheumatologist. 2015;37:43-47. https://doi.org/10.1016/j.ejr.2015.04.001
- Hsu CY, Lin M-S, SuYu-J et al. Cumulative immunosuppressant exposure is associated with diversified cancer risk among 14 832 patients with systemic lupus erythematosus: a nested case-control study. Rheumatol (Oxford). 2017;56:620-628. https://doi.org/10.1093/rheumatology/kex255
- Iaccarino L, Andreoli L, Bartoloni Boc E et al. Clinical predictors of response and discontinuation of belimumab in patients with systemic lupus erythematosus in real life setting. Results of a large, multicentric, nationwide study. J Autoimmun. 2018;86:1-8. https://doi.org/10.1016/j.jaut.2017.09.004
- Justiz Vaillant AA, Goyal A, Bansal P et al. Systemic Lupus Erythematosus (SLE). StatPearls Publishing, Treasure Island (FL), 2020 Jan.
- Ju-Yang Jung, Chang-Hee Suh. Infection in systemic lupus erythematosus, similarities, and differences with lupus flare. Korean J Intern Med. 2017;32(3):429-438. https://doi.org/10.3904/kjim.2016.234
- Kay SD, Poulsen MK, Diederichsen AC, Voss A. Coronary, Carotid, and Lower-extremity Atherosclerosis and Their Interrelationship in Danish Patients with Systemic Lupus Erythematosus. J Rheumatol. 2016;43(2):315-322. https://doi.org/10.3899/jrheum.150488
- Keeling SO, Alabdurubalnabi Z, Avina-Zubieta A, Barr S, Bergeron L, Bernatsky S et al. Canadian Rheumatology Association Recommendations for the Assessment and Monitoring of Systemic Lupus Erythematosus. J Rheumatol. 2018;45(9):1340-1355. https://doi.org/10.3899/jrheum.171459
- Khairy N, Ezzat Y, Naeem N, Taha R, Wesam R. Atherosclerosis biomarkers in female systemic lupus erythematosus patients with and without cardiovascular diseases. Egyptian Rheumatologist. 2017;39:7-12. https://doi.org/10.1016/j.ejr.2016.03.003
- Kiani AN, Aukrust P, Ueland T, Hollan I, Barr E, Magder LS, Petri M. Serum osteoprotegеrin (OPG) in subclinical atherosclerosis in systemic lupus erythematosus. Lupus. 2017;26(8):865-870. https://doi.org/10.1177/0961203316682101
- Kim CH, Al-Kindi SG, Jandali B. Incidence and risk of heart failure in systemic lupus erythematosus. Heart. 2017;103(3):227-233. https://doi.org/10.1136/heartjnl-2016-309561
- Kim D, Choi J, Cho SK. Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rheum. 2017;46(6):782-787. https://doi.org/10.1016/j.semarthrit.2016.09.004
- Klyukvina NG. Systemic lupus erythematosus and vitamin D. Modern Rheumatology. 2015;9(2):57-65 (Russian) https://doi.org/10.14412/1996-7012-2015-2-57-65
- Kovalenko VM, Kornatsky VM, editor. Stress and cardiovascular diseases. Kyiv: State Institution “National Research Center” Institute of Cardiology named after Acad. Strazchesko MD»; 2015. 356 p. (Ukrainian)
- Kovalenko VM, Kornatsky VM. The health of the people of Ukraine and tertiary health care: a guide. K.: SI NSC Institute of Cardiology named after Acad. Strazchesko MD; 2019. 193 p. (Ukrainian)
- Kovalenko VM, Rekalov DG, Yatsyshyn RI at al. Systemic lupus erythematosus (clinical guidelines). K.: Ukrainian Association of Rheumatologists; 2020. 74 p. (Ukrainian)
- Kovalenko VN, Gnilorybov AM, Ter-Vartanian CH, Yaremenko ОB. 2014 EULAR Congress (Paris, 11-14 June): the review of congress materials. Ukrainian Journal of Rheumatology. 2014;4:11-20 (Ukrainian)
- Kovalenko VN, Golovach IYu, Bortkevych OP. Achievements treatment of systemic lupus erythematosus. Ukrainian Journal of Rheumatology. 2012;50(4):16-22 (Ukrainian)
- Kuchinskaya EM, Suspitsyn EN, Kostik MM. Genetic aspects of the pathogenesis of systemic lupus erythematosus in children. Modern Rheumatology. 2020;14(1):101-107 (Russian) https://doi.org/10.14412/1996-7012-2020-1-101-107
- Kurien BT, Fesmire J, Anderson CJ, Scofield RH. Anti-Ro and Concomitant Anti-La Autoantibodies Strongly Associated With Anti-oxLDL or Anti-Phospholipid Antibody in Systemic Lupus Erythematosus. J Clin Rheumatol. 2016;22(8):418-425. https://doi.org/10.1097/RHU.0000000000000429
- Lam NC, Ghetu MV, Bieniek ML. Systemic Lupus Erythematosus: Primary Care Approach to Diagnosis and Management. Am Fam Physician. 2016;94(4):284-294.
- Langkilde H, Voss A, Heegaard N, Laustrup H. Autoantibodies persist in relatives to systemic lupus erythematosus patients during 12 years follow-up. Lupus. 2017;26(7):723-728. https://doi.org/10.1177/0961203316676378
- Larosa M, Iaccarino L, Gatto M. Advances in the diagnosis and classification of systemic lupus erythematosus. Exp Rev Clin Immunol. 2016;12(12):1309-1320. https://doi.org/10.1080/1744666X.2016.1206470
- Lewandowski LB, Kaplan MJ. Update on cardiovascular disease in lupus. Curr Opin Rheumatol. 2016;28(5):468-476. https://doi.org/10.1097/BOR.0000000000000307
- Lewis MJ, Jawad AS. The effect of ethnicity and genetic ancestry on the epidemiology, clinical features and outcome of systemic lupus erythematosus. Rheumatology (Oxford). 2016;56:67-77. https://doi.org/10.1093/rheumatology/kew399
- Li S, Liu S, Chen F. Link-Polymorphism of 5-HTT Promoter Region Is Associated with Autoantibodies in Patients with Systemic Lupus Erythematosus. J Immunol Res. 2016;2016:1-6. https://doi.org/10.1155/2016/3042726
- Lila VA. Clinical and laboratory relationships in patients with different variants of systemic lupus erythematosus. Modern rheumatology. 2020;14(1):26-31 (Russian) https://doi.org/10.14412/1996-7012-2020-1-26-31
- Little J, Parker B, Lunt M, Hanly JG, Urowitz MB, Clarke AE, et al. Glucocorticoid use and factors associated with variability in this use in the Systemic Lupus International Collaborating Clinics Inception Cohort Rheumatology (Oxford, England). 2018;57(4):677-687.
- Liu Y, Cui Y, Zhang X, Gao X, Su Y, Xu B. Effects of salvianolate on bone metabolism in glucocorticoid-treated lupus-prone B6.MRL-Faslpr/J mice. Drug Des Devel Ther. 2016;10:2535-2546. https://doi.org/10.2147/DDDT.S110125
- Lo MS, Tsokos GC. Recent developments in systemic lupus erythematosus pathogenesis and applications for therapy. Curr Opin Rheumatol. 2018;30(2):222-228. https://doi.org/10.1097/BOR.0000000000000474
- Lood C, Tydén H, Gullstrand B. Decreased platelet size is associated with platelet activation and anti-phospholipid syndrome in systemic lupus erythematosus. Rheumatology (Oxford). 2017;56(3):408-416. https://doi.org/10.1093/rheumatology/kex216
- Louthrenoo W. Treatment considerations in patients with concomitant viral infection and autoimmune rheumatic diseases. Best Pract Res Clin Rheumatol. 2015;29(2):319-342. https://doi.org/10.1016/j.berh.2015.05.010
- Macedo ACL, Isaac L. Systemic Lupus Erythematosus and Deficiencies of Early Components of the Complement Classical Pathway. Front Immunol. 2016;7:55. https://doi.org/10.3389/fimmu.2016.00055
- Mackay M, Oswald M, Sanchez-Guerrero J, Lichauco J, Aranow C, Kotkin S, et al. Molecular signatures in systemic lupus erythematosus: distinction between disease flare and infection. Lupus Sci Med. 2016;3:1-10. https://doi.org/10.1136/lupus-2016-000159
- Marushko EY. Clinical, immunological and morphofunctional characteristics of the cardiovascular system in children with juvenile rheumatoid arthritis and systemic lupus erythematosus [dissertation]. K.: National Academy of Medical Sciences of Ukraine, Institute of Pediatrics, Obstetrics and Gynecology; 2014. 24 р. (Ukrainian)
- Medeiros MM, de Oliveira IMX, Ribeiro AT. Prevalence of metabolic syndrome in a cohort of systemic lupus erythematosus patients from Northeastern Brazil: association with disease activity, nephritis, smoking, and age. Rheumatol Int. 2016;36(1):117-124. https://doi.org/10.1007/s00296-015-3316-z
- Mirfeizi Z, Poorzand H, Javanbakht A, Khajedaluee M. Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems. Iran Red Crescent Med J. 2016;18(8):e38045. https://doi.org/10.5812/ircmj.38045
- Mok CC, Ying SKY, Ma KM, Wong CK. Effect of raloxifene on disease activity and vascular biomarkers in patients with systemic lupus erythematosus: Subgroup analysis of a double-blind randomized controlled trial. Lupus. 2013;22:1470-1478. https://doi.org/10.1177/0961203313507987
- Moya FB, Pineda Galindo LF, García de la Pena M. Impact of Chronic Glucocorticoid Treatment on Cardiovascular Risk Profile in Patients with Systemic Lupus Erythematosus. J Clin Rheumatol. 2016;22(1):8-12. https://doi.org/10.1097/RHU.0000000000000335
- Mukvich OM, Omelchenko LI, Belska OA, Dudka IV, Ludvik TA, Matskevich AM. Complex issues of early diagnosis of systemic lupus erythematosus in children. The Health of the Child. 2020;15(2):112-119 (Ukrainian) https://doi.org/10.22141/2224-0551.15.2.2020.200274
- Munoz-Grajales C, Gonzalez LA, Alarcon GS, Acosta-Reyes J. Gender differences in disease activity and clinical features in newly diagnosed systemic lupus erythematosus patients. Lupus. 2016;25:1217-1223. https://doi.org/10.1177/0961203316635286
- Murdaca G, Orsi A, Spano F, Faccio V, Puppo F, Durando P, et al. Vaccine-preventable infections in systemic lupus erythematosus. Hum Vaccin Immunother. 2016;12(3):632-643. https://doi.org/10.1080/21645515.2015.1107685
- Mykhailovskaya NS, Shevchenko IO, Zelenina OA. Pathogenetic relationship between coronary heart disease and osteopenic syndrome. Zaporozhye Medical Journal. 2015;1:105-110 (Ukrainian) https://doi.org/10.14739/2310-1210.2015.1.39876
- Nascif AK, Hilario MO, Terreri MT. Endothelial function analysis and atherosclerotic rick factors in adolescents with systemic lupus erythematosus. Int J Adolesc Med Health. 2007;19(4):497-505. https://doi.org/10.1515/IJAMH.2007.19.4.497
- Neto NSR, Muniz LF, Costa LP. Herpes Zoster Ophthalmicus in a Patient with Systemic Lupus Erythematosus and Antiphospholipid Syndrome. Turk J Rheumatol. 2012;27(4):273-274. https://doi.org/10.5606/tjr.2012.050
- Ngaіdé AA, Ly F, Ly K. Cardiovascular manifestations in systemic lupus erythematosus in Dakar: Descriptive study about 50 cases. Bull Soc Pathol Exot. 2016;109(5):345-352. https://doi.org/10.1007/s13149-016-0529-7
- Nikpour M, Gladman DD, Urowitz MB. Premature coronary heart disease in systemic lupus erythematosus: what risk factor do we understand? Lupus. 2013;22:1243-1250. https://doi.org/10.1177/0961203313493031
- Nossent JC, Raymond WD, Eilertsen GO. Increased von Willebrand factor levels in patients with systemic lupus erythematosus reflect inflammation rather than increased propensity for platelet activation. Lupus Sci Med. 2016;3:e000162. https://doi.org/10.1136/lupus-2016-000162
- Olesińska M, Saletra A. Quality of life in systemic lupus erythematosus and its measurement. Reumatol. 2018;56(1):45-54. https://doi.org/10.5114/reum.2018.74750
- Pakchotanon R, Gladman DD, Su J, Urowitz MB. More Consistent Antimalarial Intake in First 5 Years of Disease Is Associated with Better Prognosis in Patients with Systemic Lupus Erythematosus. J Rheumatol. 2018;45(1):90-94. https://doi.org/10.3899/jrheum.170645
- Panchal L, Divate S, Vaideeswar P. Cardiovascular involvement in systemic lupus erythematosus: an autopsy study of 27 patients in India. J Postgrad Med. 2006;52:5-10.
- Paradowska-Gorycka A, Felis-Giemza A, Olesińska M, Haładyj E. Immunity and early atherosclerosis in the course of systemic lupus erythematosus, mixed connective tissue disease and antiphospholipid syndrome. Reumatologia. 2016;54(4):187-195. https://doi.org/10.5114/reum.2016.62473
- Park JK, Kim JY, Moon JY. Altered lipoproteins in patients with systemic lupus erythematosus are associated with augmented oxidative stress: a potential role in atherosclerosis. Arthritis Res Ther. 2016;18(1):306. https://doi.org/10.1186/s13075-016-1204-x
- Pérez-Sánchez C, Aguirre MA, Ruiz-Limón P. Atherothrombosis-associated microRNAs in Antiphospholipid syndrome and Systemic Lupus Erythematosus patients. Sci Rep. 2016;6:31375. https://doi.org/10.1038/srep31375
- Petrі M. Use of hydroxychloroquine to prevent thrombosis in systemic lupus erythematosus and in antiphospholipid antibody-positive patients. Curr Rheumatol Rep. 2011;13:77-80. https://doi.org/10.1007/s11926-010-0141-y
- Protsenko GO, Dubas VV. Systemic lupus erythematosus: the state of the problem in Ukraine and the world. Ukrainian Journal of Rheumatology. 2020;4(82):25-34 (Ukrainian)
- Rees F, Doherty M, Grainge MJ et al. The worldwide incidence and prevalence of systemic lupus erythematosus: a systematic review of epidemiological studies. Rheumatol (Oxford). 2017;56(11):1945-1961. https://doi.org/10.1093/rheumatology/kex260
- Rentero ML, Amigo E, Chozas N et al. Prevalence of fractures in women with rheumatoid arthritis and/or systemic lupus erythematosus on chronic glucocorticoid therapy. BMC Musculoskelet. Disord. 2015;16:300. https://doi.org/10.1186/s12891-015-0733-9
- Rigante D, Esposito S. Infections and Systemic Lupus Erythematosus: Binding or Sparring Partners? Int J Mol Sci. 2015;(16):17331-17343. https://doi.org/10.3390/ijms160817331
- Robert J Lahita. Systemic lupus erythematosus. 4th edition. Elsevier Inc.; 2004. 913-942 р. https://doi.org/10.1016/B9-78-012433-9/01950-034X
- Rodríguez Huerta MD, Trujillo-Martín MM, Rúa-Figueroa Í et al. Healthy lifestyle habits for patients with systemic lupus erythematosus: A systemic review. Semin Arthritis Rheum. 2016;45(4):463-470. https://doi.org/10.1016/j.semarthrit.2015.09.003
- Romero-Díaz J, Acosta-Hernández RI, Criales-Vera S, Kimura-Hayama E, Domínguez-Quintana M, Morán-Contla R et al. Asymptomatic Coronary Artery Calcifications in Men with Systemic Lupus Erythematosus. J Rheumatol. 2018;45(5):663-670. https://doi.org/10.3899/jrheum.170330
- Romero-Diaz J, Vargas-Vorackova F, Kimura-Hayama E, Cortazar-Benitez LF, Gijon-Mitre R, Criales S et al. Systemic lupus erythematosus risk factors for coronary artery calcifications. Rheumatology. 2012;51:110-119. https://doi.org/10.1093/rheumatology/ker307
- Ruiz-Arruza I, Ugarte A, Cabezas-Rodriguez I et al. Glucocorticoids and irreversible damage in patients with systemic lupus erythematosus. Rheumatology (Oxford). 2014;53(8):1470-1476. https://doi.org/10.1093/rheumatology/keu148
- Sacre K, Escoubet B, Zennaro MC. Overweight Is a Major Contributor to Atherosclerosis in Systemic Lupus Erythematosus Patients at Apparent Low Risk for Cardiovascular Disease: A Cross-Sectional Controlled Study. Medicine (Baltimore). 2015;94(48):e2177. https://doi.org/10.1097/MD.0000000000002177
- Sakir GY, Atılgan CU, Tekin K et al. Validity of Optical Coherence Tomography Angiography as a Screening Test for the Early Detection of Retinal Changes in Patients with Hydroxychloroquine Therapy. J Curr Eye Res. 2019;44(3):311-315. https://doi.org/10.1080/02713683.2018.1545912
- Santos EC, Pinto AC, Klumb EM, Macedo JM. Polymorphisms in NAT2 (N-acetyltransferase 2) gene in patients with systemic lupus erythematosus. Rev Bras Reumatol Engl Ed. 2016;56(6):521-529. https://doi.org/10.1016/j.rbr.2016.07.007
- Sarabi ZS, Sahebari M, Rezaie AE, Norouzi MT, Hashemzadeh K, Mirfeizi Z. Relationship between Systemic Lupus Erythematosus activity and Persistent Positive Antiphospholipid Antibodies. Curr Rheumatol Rev. 2018;14(2):145-152. https://doi.org/10.2174/1573397113666161122152553
- Sebastiani GD, Prevete I, Iuliano A, Minisola G. The Importance of an Early Diagnosis in Systemic Lupus Erythematosus. Isr Med Assoc J. 2016;18(3-4):212-215.
- Sharma SK, Rathi M, Sahoo S. Assessment of premature atherosclerosis in systemic lupus erythematosus patients with and without nephritis. Lupus. 2016;25(5):525-531. https://doi.org/10.1177/0961203315622822
- Shevchuk SV. Thrombocytopenia as a Marker of Cardiovascular Lesions in SLE. Bulletin of Problems of Biology and Medicine. 2014;(4):186-190 (Ukrainian)21
- Silva JA, Lima SC, Addobbati C et al. Association of interferon-induced helicase C domain (IFIH1) gene polymorphisms with systemic lupus erythematosus and a relevant updated meta-analysis. Genet Mol Res. 2016;15(4). https://doi.org/10.4238/gmr15048008
- Singh JA, Hossain A, Kotb A et al. Risk of serious infections with immunosuppressive drugs and glucocorticoids for lupus nephritis: a systematic review and network meta-analysis. BMC Med. 2016;14(1):137-140. https://doi.org/10.1186/s12916-016-0673-8
- Sinyachenko PO, Ignatenko GA, Dyadyk EA. Endocardium defeat and heart valves at patients with systemic lupus erythematosus (сlinico-morphological comparisons). Ukrainian morphological Almanac. 2011;14(3):149-151) (Ukrainian)
- Sisirak V, Ganguly D, Lewis KL, Couillault C, Tanaka L, Bolland S et al. Genetic evidence for the role of plasmacytoid dendritic cells in systemic lupus erythematosus. J Exp Med. 2014;211(10):1969-1976. https://doi.org/10.1084/jem.20132522
- Smrzova A, Horak P, Skacelova M et al. Intima media thickness measurement as a marker of subclinical atherosclerosis in SLE patient. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2014;158(3):404-411. https://doi.org/10.5507/bp.2013.054
- Solhjoo M, Bansal P, Goyal A et al. Drug-Induced Lupus Erythematosus. StatPearls Publishing, Treasure Island (FL), 2020 Jan.
- Soyuöz A, Karadağ Ö, Karaağaç T et al. Therapeutic plasma exchange for refractory SLE: A comparison of outcomes between different sub-phenotypes. Eur J Rheumatol. 2018;5(1):32-36. https://doi.org/10.5152/eurjrheum.2017.17088
- Staveri C, Karokis D, Liossis SC. New onset of lupus nephritis in two patients with SLE shortly after initiation of treatment with belimumab. Semin Arthritis Rheum. 2017;46(6):788-790. https://doi.org/10.1016/j.semarthrit.2016.09.006
- Steiman AJ, Urowitz MB, Ibañez D, Li TT, Gladman DD, Wither J. Anti-dsDNA and Antichromatin Antibody Isotypes in Serologically Active Clinically Quiescent Systemic Lupus Erythematosus. J Rheumatol. 2015;42(5):810-816. https://doi.org/10.3899/jrheum.140796
- Stojan G, Petri M. Epidemiology of systemic lupus erythematosus: an update. Curr Opin Rheumatol. 2018;30(2):144-150. https://doi.org/10.1097/BOR.0000000000000480
- Suárez-Fueyo A, Bradley SJ, Tsokos GC. T cells in Systemic Lupus Erythematosus. Curr Opin Immunol. 2016;43:32-38. https://doi.org/10.1016/j.coi.2016.09.001
- Tamaki K, Morishima S, Nakachi S. An atypical case of late-onset systemic lupus erythematosus with systemic lymphadenopathy and severe autoimmune thrombocytopenia/neutropenia mimicking malignant lymphoma. Int J Hematol. 2016;8:1-6.
- Tarr T, Papp G, Nagy N. Chronic high-dose glucocorticoid therapy triggers the development of chronic organ damage and worsens disease outcome in systemic lupus erythematosus. Clin Rheumatol. 2017;36:327-333. https://doi.org/10.1007/s10067-016-3492-6
- Tazi Z, Harmouche H, Ammouri W, Maamar M, Adnaoui M, Cacoub P. Atherosclerosis in systemic lupus erythematosus. Presse Med. 2014;43(10):1034-1047. https://doi.org/10.1016/j.lpm.2014.01.021
- Thomas G, Aubart FC, Chiche L et al. Lupus Myocarditis: Initial Presentation and Longterm Outcomes in a Multicentric Series of 29 Patients. J Rheumatol. 2017;44(1):24-32. https://doi.org/10.3899/jrheum.160493
- Touma Z, Gladman DD, Su J, Anderson N, Urowitz MB. A novel lupus activity index accounting for glucocorticoids: SLEDAI-2K glucocorticoid index. Rheumatol (Oxford, England). 2018;57(8):1370-1376. https://doi.org/10.1093/rheumatology/key103
- Troldborg A, Thiel S, Trendelenburg M, Friebus-Kardash J, Nehring J, Steffensen R et al. The Lectin Pathway of Complement Activation in Patients with Systemic Lupus Erythematosus. J Rheumatol. 2018;45(8):1136-1144. https://doi.org/10.3899/jrheum.171033
- Truszewska A, Foroncewicz B, Pączek L. The role and diagnostic value of cell-free DNA in systemic lupus erythematosus. Clin Exp Rheumatol. 2016. – Access mode : http://www.clinexprheumatol.org/abstract.aspa=10715.
- Tsang-A-Sjoe MW, Bultink IE, Heslinga M et al. Both prolonged remission and Lupus Low Disease Activity State are associated with reduced damage accrual in systemic lupus erythematosus. Rheumatol. (Oxford). 2017;56(1):121-128. https://doi.org/10.1093/rheumatology/kew377
- Tselios K, Deeb M, Gladman DD, Harvey P, Akhtari S, Mak S et al. Antimalarial-induced Cardiomyopathy in Systemic Lupus Erythematosus: As Rare as Considered? J Rheumatol. 2019;46(4):391-396. https://doi.org/10.3899/jrheum.180124
- Tselios K, Gladman DD, Touma Z et al. Clinical remission and low disease activity have comparable outcomes over 10 years in systemic lupus erythematosus. Arthritis Care Res. (Hoboken). 2019;71(6):822-828. https://doi.org/10.1002/acr.23720
- Tselios K, Gladman DD, Urowitz MB. Systemic lupus erythematosus and pulmonary arterial hypertension: links, risks, and management strategies. Open Access Rheumatol. 2017;9:1-9. https://doi.org/10.2147/OARRR.S123549
- Tselios K, Koumaras C, Gladman DD, Urowitz MB. Dyslipidemia in systemic lupus erythematosus: just another comorbidity? Semin Arthritis Rheum. 2016;45(5):604-610. https://doi.org/10.1016/j.semarthrit.2015.10.010
- Tselios K, Sheane BJ, Gladman DD, Urowitz MB. Optimal Monitoring For Coronary Heart Disease Risk in Patients with Systemic Lupus Erythematosus: A Systematic Review. J Rheumatol. 2016;43(1):54-65. https://doi.org/10.3899/jrheum.150460
- Tselios K, Gladman DD, Harvey P, Akhtari S, Su J, Urowitz MB. Abnormal Cardiac Biomarkers in Patients with Systemic Lupus Erythematosus and No Prior Heart Disease: A Consequence of Antimalarials? J Rheumatol. 2019;46(1):64-69. https://doi.org/10.3899/jrheum.171436
- Tselios K, Gladman DD, Su J, Ace O, Urowitz MB. Evolution of Risk Factors for Atherosclerotic Cardiovascular Events in Systemic Lupus Erythematosus: A Longterm Prospective Study. J Rheumatol. 2017;44(12):1841-1849. https://doi.org/10.3899/jrheum.161121
- Tselios K, Gladman DD, Su J, Urowitz MB. Mycophenolate Mofetil in Nonrenal Manifestations of Systemic Lupus Erythematosus: An Observational Cohort Study. J Rheumatol. 2016;43(3):552-558. https://doi.org/10.3899/jrheum.150779
- Tselios K, Gladman DD, Urowitz MB. How can we define low disease activity in systemic lupus erythematosus? Semin Arthritis Rheum. 2019;48(6):1035-1040. https://doi.org/10.1016/j.semarthrit.2018.10.013
- Tziomalos K, Gkougkourelas I, Sarantopoulos A. Arterial stiffness and peripheral arterial disease in patients with systemic lupus erythematosus. Rheumatol Int. 2017;37(2):293-298. https://doi.org/10.1007/s00296-016-3610-4
- Ünlü O, Zuily S, Erkan D. The clinical significance of antiphospholipid antibodies in systemic lupus erythematosus. Eur J Rheumatol. 2016;3:75-84. https://doi.org/10.5152/eurjrheum.2015.0085
- Urowitz MB, Su J, Gladman DD. Atherosclerotic Vascular Events in Systemic Lupus Erythematosus – an Evolving Story. J Rheumatol. 2020;47(1):66-71. https://doi.org/10.3899/jrheum.180986
- van Vollenhoven R, Voskuyl A, Bertsias G. A framework for remission in SLE: consensus findings from a large international task force on definitions of remission in SLE (DORIS). Ann Rheum Dis. 2017;76(3):554-561. https://doi.org/10.1136/annrheumdis-2016-209519
- Volkmann ER, Grossman JM, Sahakian LJ, Skaggs BJ, Gerald JF, Ragavendra N. Low physical activity is associated with proinflammatory high density lipoprotein and increased subclinical atherosclerosis in women with systemic lupus erythematosus. Apthritis Care Res. 2010;62(2):258-265. https://doi.org/10.1002/acr.20076
- Vukelic M, Li Y, Kyttaris VC. Novel Treatments in Lupus. Front Immunol. 2018;9:2658. https://doi.org/10.3389/fimmu.2018.02658
- Wang H, Cao J, Lai X. Serum Interleukin-34 Levels Are Elevated in Patients with Systemic Lupus Erythematosus. Molecules. 2017;22(35):1-8. https://doi.org/10.3390/molecules22010035
- Watad A, Abu Much A, Bracco D. Association between ischemic heart disease and systemic lupus erythematosus-a large case-control study. Immunol Res. 2017;64(153):1-5. https://doi.org/10.1007/s12026-016-8884-9
- Wu GC, Liu HR, Leng RX, Li XP, Li XM, Pan HF, Ye DQ. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmun Rev. 2016;15(1):22-37. https://doi.org/10.1016/j.autrev.2015.10.002
- Yaremenko OB, Petelytska LB. Systemic lupus erythematosus: clinically significant aspects. https://health-ua.com/article/5704-sistemnij-chervonij-vovchak-klnchno-znachush-aspekti). (Ukrainian)
- Yelnik CM, Richey M, Haiduc V. Cardiovascular Disease Prevention Counseling Program for Systemic Lupus Erythematosus Patients. Arthritis Care Res. (Hoboken). 2017;69(8):1209-1216. https://doi.org/10.1002/acr.23128
- Yeung KS, Chung BH, Choufani S et al. Genome-Wide DNA Methylation Analysis of Chinese Patients with Systemic Lupus Erythematosus Identified Hypomethylation in Genes Related to the Type I Interferon Pathway. PLoS One. 2017;12(1):e0169553. https://doi.org/10.1371/journal.pone.0169553
- Young NA, Valiente GR, Hampton JM. Estrogen-regulated STAT1 activation promotes TLR8 expression to facilitate signaling via microRNA-21 in systemic lupus erythematosus. Clin Immunol. 2016;176:12-22. https://doi.org/10.1016/j.clim.2016.12.005
- Yung S, Chan TM. Mechanisms of Kidney Injury in Lupus Nephritis – the Role of Anti-dsDNA Antibodies. Front Immunol. 2015;6:475. https://doi.org/10.3389/fimmu.2015.00475